ImmunoCure is now Pozescaf. Launches New Era in Drug Discovery

ImmunoCure Inc., a pioneering biotech company in AI based drug discovery and development, officially announced its rebranding to Pozescaf during a landmark event held at its R&D facility located at the Genome Valley, Shamirpet, Medchal-Malkajgiri Dist, Hyderabad, Telangana-500078.

The event featured the launch of the new corporate website by Dr. Srinivas Guntha, Managing Director of AAP Pharma Technologies India Pvt. Ltd., key company leaders and stakeholders attended the ceremony, including Cofounders Dr. Ravikumar Muttineni, Dr. Kranthi Raj Kodamala, Dr. Murali Ginjupalli and CEO Mr. Nagesh Bethamcherla. Senior members of the scientific and technical leadership Dr. Ramesh Reddigunta, Dr. Amit Kumar Shrivastava and Mr. Bhanukishore Kallepalli were also present.

Dr. Kranthi Raj Kodamala was formally welcomed as the new Chief Scientist Officer (CSO). Dr. Ravikumar Muttineni extended a warm welcome to Dr. Kodamala, while Dr. Murali Ginjupalli introduced the entire leadership team to mark the occasion.

This rebranding is more than a name change — it represents our strategic growth, our commitment to innovative science and our readiness to deliver solutions that make a global impact, said CEO Mr. Nagesh Bethamcherla.

The company’s new brand identity and website are now live at www.pozescaf.com.

Tags-ImmunoCure is now Pozescaf. Launches New Era in Drug Discovery

bodyimages:

JOIN OUR WHATSAPP CHANNEL FOR MORE UPDATES